MAPT and Parkinson disease: In addition to documented pathogenic mutations in PD genes, common genetic variants in at least three genes, apolipoprotein E (APOE), microtubule-associated protein tau (MAPT), and α-synuclein (SNCA), may play a role in the eventual susceptibility to cognitive impairment in PD patients.